| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/2003 | US6620834 Medicinal compositions for treating colorectal cancer |
| 09/16/2003 | US6620833 Coccidiosis treatment; 4,5-tetrafluoroethylenedioxybenzimidazole derivatives |
| 09/16/2003 | US6620832 Substituted ureas |
| 09/16/2003 | US6620831 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 09/16/2003 | US6620829 Administering a therapeutically effective amount of a GABA analog having characteristic of being an inhibitor of cartilage damage, or a pharmaceutically acceptable salt |
| 09/16/2003 | US6620828 Antiproliferative agents |
| 09/16/2003 | US6620827 PPARγ modulators |
| 09/16/2003 | US6620825 Adenosine A3 receptor antagonists |
| 09/16/2003 | US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/16/2003 | US6620819 Anticonvulsant derivatives useful in treating psychosis |
| 09/16/2003 | US6620818 Administering indolin-2-one derivative as cyclin-dependent kinase inhibitor |
| 09/16/2003 | US6620816 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide |
| 09/16/2003 | US6620815 Oxazolidinones and uses thereof |
| 09/16/2003 | US6620814 Mixture with partially neutralized pH-dependent binder; antiarrhythmia agents; cardiovascular disorders, myocardium infarction |
| 09/16/2003 | US6620813 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 09/16/2003 | US6620811 Isonicotin- and nicotinamide derivatives of benzothiazoles |
| 09/16/2003 | US6620810 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
| 09/16/2003 | US6620809 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds |
| 09/16/2003 | US6620808 For stimulation of endogenous hormones; aging resistance |
| 09/16/2003 | US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon |
| 09/16/2003 | US6620805 Drug delivery of antihepatitis viricide to hepatocytes |
| 09/16/2003 | US6620803 Cosmetic or dermatological use of 7-hydroxylated steroids |
| 09/16/2003 | US6620802 Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist |
| 09/16/2003 | US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/16/2003 | US6620798 Synergistic agents for enhancing tissue repair |
| 09/16/2003 | US6620795 Expressing an exogenously supplied gene in cells of the airway are disclosed. Lipid carrier-nucleic acid complexes or nucleic acid abre are prepared then delivered via aerosol or systemically to the lung abre or lung plus extrapulmonary |
| 09/16/2003 | US6620793 Administration of methylprednisolone or ester thereof within 8 hours after occurrence of injury, and after completion of administration of methylprednisolone but within 24-72 hours after injury, administration of ganglioside GM1 |
| 09/16/2003 | US6620792 Monosialoganglioside GM1 or a derivative thereof, namely, the inner ester AGF2 and the methyl ester AGF4, suitable for the treatment of Parkinson's disease. A further object of the present invention is a therapy for Parkinson's Disease |
| 09/16/2003 | US6620790 Stimulate hair growth |
| 09/16/2003 | US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs |
| 09/16/2003 | US6620788 Enteral sorbefacients |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | US6620779 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent |
| 09/16/2003 | US6620767 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| 09/16/2003 | US6620594 Uncoupling protein homologue: UCP 3 |
| 09/16/2003 | US6620442 Extract of jojoba; simmondsin ferulate may be selectively reduced or removed from the extracts using activated carbon; improves organoleptic property, palatability; feeds |
| 09/16/2003 | US6620439 Chrono delivery formulations and method of use thereof |
| 09/16/2003 | US6620438 Arylglycinamide derivatives |
| 09/16/2003 | US6620433 Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications |
| 09/16/2003 | US6620430 Plaster containing felbinac |
| 09/16/2003 | US6620429 Free active substance base is liberated, during the manufacture of the system, from active substance salts by conversion with a basic alkaline metal salt |
| 09/16/2003 | US6620428 Oral route is hampered by a low bioavailability of the drug due to an extensive first-pass metabolism and side effects such as nausea and skin disorders, like rash |
| 09/16/2003 | US6620427 Administering calcium compoound and fat blend |
| 09/16/2003 | US6620425 Food supplements and methods comprising lipoic acid and creatine |
| 09/16/2003 | US6620424 Process for producing glycolytic metabolism regulators |
| 09/16/2003 | US6620423 Ropivacaine for use as an analgesic in the treatment of muskuloskeletal pain |
| 09/16/2003 | US6620419 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 09/16/2003 | US6620418 Antiseptic/antifungal agent and endermic liniment composition which contains it |
| 09/16/2003 | US6620382 Method and compositions for treatment of cancers |
| 09/16/2003 | CA2558708A1 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| 09/16/2003 | CA2283671C Salt of naphthyridine carboxylic acid derivative |
| 09/16/2003 | CA2274133C Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them |
| 09/16/2003 | CA2267096C Pharmaceutical microspheres of valproic acid for oral administration |
| 09/16/2003 | CA2250274C Method and apparatus for preparing an acellular red blood cell substitute |
| 09/16/2003 | CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 09/16/2003 | CA2238875C Tri-aryl ethane derivatives as pde iv inhibitors |
| 09/16/2003 | CA2238736C Novel a1 adenosine receptor agonists and antagonists |
| 09/16/2003 | CA2235421C Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/16/2003 | CA2232116C Novel n-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/16/2003 | CA2231025C Novel compounds of 2-aminoindane, process for their preparation and pharmaceutical compositions containing them |
| 09/16/2003 | CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors |
| 09/16/2003 | CA2194175C Two- and three-component fungicidal mixtures |
| 09/16/2003 | CA2167408C Process for making hiv protease inhibitors |
| 09/16/2003 | CA2142610C Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| 09/16/2003 | CA2130577C Combinations of ace inhibitors and diuretics |
| 09/16/2003 | CA2119463C Glial cell line-derived neutrophic factor |
| 09/16/2003 | CA2107219C S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| 09/16/2003 | CA2105683C N-¬¬4,5-dihydroxy-and 4,5,8-trihydroxy-9,10-dihydro-9, 10-dioxo-2-anthracene-yl|carbonyl|amino acids useful in the therapy of osteoarticular affections |
| 09/16/2003 | CA2102782C 2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents |
| 09/16/2003 | CA2099898C Antibacterial antiplaque oral composition |
| 09/16/2003 | CA2086206C Hypocariogenic hydrogenated starch hydrolysate, process for preparing it and the application of this hydrolysate |
| 09/16/2003 | CA2081343C Therapeutic agents for the treatment of multidrug resistance to cancers |
| 09/16/2003 | CA2078759C Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 09/16/2003 | CA2047857C (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| 09/16/2003 | CA2046429C Imide derivatives, and their production and use |
| 09/16/2003 | CA2037575C N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives |
| 09/16/2003 | CA2025490C Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/12/2003 | WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 09/12/2003 | WO2003074736A1 Diagnostics and remedies for malignant brain tumor |
| 09/12/2003 | WO2003074735A1 Diagnostic method for glaucoma |
| 09/12/2003 | WO2003074732A2 Methods based on hormone dependency of primary cancer cells |
| 09/12/2003 | WO2003074703A1 Novel transcriptional factor, dna thereof and use of the same |
| 09/12/2003 | WO2003074702A1 Novel protein and dna thereof |
| 09/12/2003 | WO2003074694A1 Adipocyte differentiation-associated genes and proteins |
| 09/12/2003 | WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/12/2003 | WO2003074570A1 Novel branched sialo-sugar molecules and antiviral agents using the same |
| 09/12/2003 | WO2003074550A2 Pin1-modulating compounds and methods of use thereof |
| 09/12/2003 | WO2003074543A1 Anti-protozoal vaccine |
| 09/12/2003 | WO2003074532A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase |
| 09/12/2003 | WO2003074531A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity |
| 09/12/2003 | WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 09/12/2003 | WO2003074529A2 iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS |
| 09/12/2003 | WO2003074527A1 Crystalline polymorphic form of irinotecan hydrochloride |
| 09/12/2003 | WO2003074522A1 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one |
| 09/12/2003 | WO2003074521A1 Derivatives of epothilone b and d and synthesis thereof |
| 09/12/2003 | WO2003074520A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain |
| 09/12/2003 | WO2003074517A1 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 09/12/2003 | WO2003074516A1 Phthalimide carboxylic acid derivatives |
| 09/12/2003 | WO2003074515A1 Diamino-pyrimidines and their use as angiogenesis inhibitors |